SynthesisPLoS medicine2022
The global prevalence of female genital mutilation/cutting: A systematic review and meta-analysis of national, regional, facility, and school-based studies.
Synthesis in PLoS medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Health effects associated with exposure of children to physical violence, psychological violence and neglect: a Burden of Proof study.Nature human behaviour · 2025Pooled it
- "All you Gain is Pain and Sorrow": Facilitators and Barriers to the Prevention of Female Genital Mutilation in High-income Countries.Trauma, violence & abuse · 2024Pooled it
- Prevalence of female genital mutilation and associated factors among women and girls in Africa: a systematic review and meta-analysis.Systematic reviews · 2024Pooled it
- Unexplored avenues: a narrative review of cognition and mood in postmenopausal African women with female genital circumcision/mutilation/cutting.Frontiers in global women's health · 2024Pooled it
- Prevalence and Temporal Trends of Female Genital Cutting Among Women in Sierra Leone.International urogynecology journal · 2026Article
- Transnational strategies to promote female circumcision practice: voices from ghanaian families with relatives living in Europe and North America.BMC women's health · 2026Article
- Determinants of female genital mutilation among daughters in Ethiopia: a negative binomial regression approach.BMC public health · 2026Article
- Determinants of precancerous cervical lesions among women screened for cervical cancer at Debre Markos town public health facilities, Ethiopia.Reproductive health · 2026Article
- Impact of female genital mutilation on sexual function and psychosocial wellbeing among Somali women: a cross-sectional study.BMC women's health · 2026Observational
- Female genital mutilation: prevalence and factors associated with its type among women of reproductive age group in Somaliland: further analysis of 2020 Demographic and Health Survey Data.Archives of public health = Archives belges de sante publique · 2026Article
- Paraclitoral cystic lesions after female genital mutilation: a clinicopathologic evaluation from Mogadishu.BMC women's health · 2026Article
- Universal Female Genital Mutilation and High Burden of Infibulation in Mogadishu: Cross-Sectional Study on Severity, Types, and Associated Factors Among Adolescent Girls in Somalia.Health science reports · 2026Article
- Evaluating the effectiveness of the violence against persons prohibition act in reducing female genital mutilation/cutting in Nigeria: a multi-year policy impact analysis.BMC research notes · 2026Article
- Female genital mutilation/cutting burden and perceptions among asylum-seeking women in Berlin, Germany: A cross-sectional study.Journal of migration and health · 2026Article
- Effects of Training Nursing Students on Female Genital Mutilation: A Quasi-Experimental Study With Pre- and Postintervention Assessments.Nursing research and practice · 2026Article
- Lived experiences and impacts of female genital mutilation/cutting (FGM/C): a meta-ethnographic synthesis.BMJ public health · 2026Article
- "Frontiers in global women's health · 2026Article
- Factors associated with female genital mutilation/cutting in Tanzania: insights from Tanzania demographic and health survey 2022.BMC women's health · 2025Article
- [Validation of a questionnaire on knowledge, attitudes, and healthcare approaches to female genital mutilation among nursing students: A pilot study].Anales del sistema sanitario de Navarra · 2025Article
- Prevalence and determinants of female genital mutilation: current insights from ten at-risk countries in Sub-Saharan Africa.BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFemale genital mutilation/cutting (FGM/C) is a nonmedical procedure entailing the modification of the external female genitalia. A description of the prevalence and distribution of FGM/C allows the tracking of progress toward ending FGM/C by 2030 (Sustainable Development Goal (SDG): target 5.3). This systematic review aimed to examine FGM/C prevalence and types, by World Health Organization (WHO) region and country. METHODS AND
findingsA systematic search using Medical Subject Headings (MeSH) and keywords from 2009 to March 24, 2022 was undertaken in MEDLINE, PubMED, PsycINFO, Web of Science, and Embase to identify studies presenting FGM/C prevalence. Abstract and full-text screening, quality assessment, and data extraction were undertaken by 2 reviewers. Only nationally representative studies were included in the meta-analysis. Pooled FGM/C prevalence was estimated by random-effects meta-analysis using generalized linear mixed models (GLMMs). FGM/C prevalence with 95% confidence intervals (CIs), prediction intervals (PIs), and FGM/C type were presented separately by women aged 15 to 49 years and girls aged 0 to 14 years. A total of 163 studies met the inclusion criteria and 30 were included in the meta-analysis, of which 23 were from the WHO African Region (AFR), 6 from the Eastern Mediterranean Region (EMR), and 1 from the South East Asian Region (SEAR). These studies included data from 406,068 women across 30 countries and 296,267 girls across 25 countries; the pooled prevalence estimate of FGM/C among women aged 15 to 49 years was 36.9% (95% CI: 19.6% to 58.3%; PI: 0.4% to 99.0%), and 8.27% (95% CI: 3.7% to 17.3%; PI: 0.1% to 89.3%) among girls aged 0 to 14 years. Among included countries, this gave a total estimated prevalence of 84,650,032 women (95% CI: 45,009,041 to 133,834,224) and 13,734,845 girls with FGM/C (95% CI: 6,211,405 to 28,731,901). Somalia had the highest FGM/C prevalence among women (99.2%), and Mali had the highest among girls (72.7%). The most common type of FGM/C among women was "flesh removed" (Type I or II) in 19 countries. Among girls, "not sewn closed" (Type I, II, or IV) and "flesh removed" (Type I or II) were the most common types in 8 countries, respectively. Among repeated nationally representative studies, FGM/C decreased for both women and girls in 26 countries. The main limitation of the study methodology is that estimates were based on available published data, which may not reflect the actual global prevalence of FGM/C.
conclusionsIn this study, we observed large variation in FGM/C prevalence between countries, and the prevalence appears to be declining in many countries, which is encouraging as it minimizes physical and physiological harm for a future generation of women. This prevalence estimate is lower than the actual global prevalence of FGM/C due to data gaps, noncomparable denominators, and unavailable surveys. Yet, considerable policy and community-level interventions are required in many countries to meet the SDG target 5.3.
trial registrationRegistration: CRD42020186937.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.